160 related articles for article (PubMed ID: 8262547)
1. Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction.
Väkevä A; Laurila P; Meri S
Immunology; 1993 Oct; 80(2):177-82. PubMed ID: 8262547
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
Väkevä A; Laurila P; Meri S
Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272
[TBL] [Abstract][Full Text] [Related]
3. Regulation of complement membrane attack complex formation in myocardial infarction.
Väkevä A; Laurila P; Meri S
Am J Pathol; 1993 Jul; 143(1):65-75. PubMed ID: 7686345
[TBL] [Abstract][Full Text] [Related]
4. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.
Schäfer H; Mathey D; Hugo F; Bhakdi S
J Immunol; 1986 Sep; 137(6):1945-9. PubMed ID: 3528291
[TBL] [Abstract][Full Text] [Related]
5. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium.
Väkevä A; Morgan BP; Tikkanen I; Helin K; Laurila P; Meri S
Am J Pathol; 1994 Jun; 144(6):1357-68. PubMed ID: 7515561
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of the terminal C5b-9 complement complexes associated to S-protein and macrophage immunoreactive deposits in human damaged myocardial areas.
Vlaicu R; Rus HG; Niculescu F
Med Interne; 1988; 26(1):21-7. PubMed ID: 3399815
[TBL] [Abstract][Full Text] [Related]
7. Dynamic expression of the membrane attack complex (MAC) of the complement system in failing human myocardium.
Oliveira GH; Brann CN; Becker K; Thohan V; Koerner MM; Loebe M; Noon GP; Torre-Amione G
Am J Cardiol; 2006 Jun; 97(11):1626-9. PubMed ID: 16728227
[TBL] [Abstract][Full Text] [Related]
8. Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.
Tada T; Okada H; Okada N; Tateyama H; Suzuki H; Takahashi Y; Eimoto T
Virchows Arch; 1997 Apr; 430(4):327-32. PubMed ID: 9134044
[TBL] [Abstract][Full Text] [Related]
9. A reexamination of the role of clusterin as a complement regulator.
Hochgrebe TT; Humphreys D; Wilson MR; Easterbrook-Smith SB
Exp Cell Res; 1999 May; 249(1):13-21. PubMed ID: 10328949
[TBL] [Abstract][Full Text] [Related]
10. Membrane attack complex (MAC) deposits in skin are not always accompanied by S-protein and clusterin.
French LE; Polla LL; Tschopp J; Schifferli JA
J Invest Dermatol; 1992 May; 98(5):758-63. PubMed ID: 1569324
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion.
Nijmeijer R; Krijnen PA; Assink J; Klaarenbeek MA; Lagrand WK; Veerhuis R; Visser CA; Meijer CJ; Niessen HW; Hack CE
Eur J Clin Invest; 2004 Dec; 34(12):803-10. PubMed ID: 15606722
[TBL] [Abstract][Full Text] [Related]
12. Intravenous clusterin administration reduces myocardial infarct size in rats.
Van Dijk A; Vermond RA; Krijnen PA; Juffermans LJ; Hahn NE; Makker SP; Aarden LA; Hack E; Spreeuwenberg M; van Rossum BC; Meischl C; Paulus WJ; Van Milligen FJ; Niessen HW
Eur J Clin Invest; 2010 Oct; 40(10):893-902. PubMed ID: 20854280
[TBL] [Abstract][Full Text] [Related]
13. Clusterin in renal tissue: preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli.
French LE; Tschopp J; Schifferli JA
Clin Exp Immunol; 1992 Jun; 88(3):389-93. PubMed ID: 1606720
[TBL] [Abstract][Full Text] [Related]
14. Temporal induction of clusterin in the peri-infarct zone after experimental myocardial infarction in the rat.
Silkensen JR; Hirsch AT; Lunzer MM; Chmielewski D; Manivel JC; Muellerleile MR; Rosenberg ME
J Lab Clin Med; 1998 Jan; 131(1):28-35. PubMed ID: 9452124
[TBL] [Abstract][Full Text] [Related]
15. Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention.
Haahr-Pedersen S; Bjerre M; Flyvbjerg A; Mogelvang R; Dominquez H; Hansen TK; Galatius S; Bech J; Madsen JK; Søgaard P; Jensen JS
J Invasive Cardiol; 2009 Jan; 21(1):13-9. PubMed ID: 19126922
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion.
Kilgore KS; Park JL; Tanhehco EJ; Booth EA; Marks RM; Lucchesi BR
J Mol Cell Cardiol; 1998 Jan; 30(1):75-85. PubMed ID: 9500866
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein activates complement in infarcted human myocardium.
Nijmeijer R; Lagrand WK; Lubbers YT; Visser CA; Meijer CJ; Niessen HW; Hack CE
Am J Pathol; 2003 Jul; 163(1):269-75. PubMed ID: 12819031
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the membrane attack complex of complement for the detection of a recent myocardial infarction in man.
Robert-Offerman SR; Leers MP; van Suylen RJ; Nap M; Daemen MJ; Theunissen PH
J Pathol; 2000 May; 191(1):48-53. PubMed ID: 10767718
[TBL] [Abstract][Full Text] [Related]
19. Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC).
Chauhan AK; Moore TL
Clin Exp Immunol; 2006 Sep; 145(3):398-406. PubMed ID: 16907906
[TBL] [Abstract][Full Text] [Related]
20. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
